You have no items in your shopping cart.
You have no items in your shopping cart.
Catalog Number | orb2806645 |
---|---|
Category | Antibodies |
Description | Galectin 9 Antibody |
Species/Host | Mouse |
Clonality | Monoclonal |
Clone Number | 1G3 |
Tested applications | Blocking, ELISA, FA, IHC, NeA, WB |
Reactivity | Human, Mouse |
Isotype | IgG |
Immunogen | The original antibody was generated by immunizing BALB/c mice with a recombinant c-terminus galectin-9 (residues 191 to 355 of the galectin-9 long isoform). |
Concentration | 1 mg/ml |
Conjugation | Unconjugated |
Target | Galectin 9 |
UniProt ID | O00182 |
Storage | Maintain refrigerated at 2-8°C for up to 2 weeks. For long term storage store at -20°C in small aliquots to prevent freeze-thaw cycles. |
Buffer/Preservatives | PBS with 0.02% Proclin 300. |
Alternative names | Galectin-9; Gal-9; LGALS9; Ecalectin; Tumor antige Read more... |
Note | For research use only |
Application notes | The binding and binding specificity of the original format of this antibody to c-terminus Gal-9 were assessed via ELISA. Epitope mapping was also done using ELISA. Furthermore, this antibody was successfully used in WB and IHC assays (Barjon et al., 2012; PMID: 22805533). An scFv-CAR version of this antibody with therapeutic potential was developed and described (US20230295564A1). This antibody was successfully used to neutralize LGALS9 in a study focused on pancreatic neoplastic lesions (Quilbe et al., 2023; PMID: 38098486). This antibody was used in a T lymphocyte proliferation assay, specifically in assessing the immunomodulatory properties of extracellular vesicles (C15SEVs) derived from nasopharyngeal carcinoma and recombinant Galectin-9S. In this assay, the antibody was used to block the impact of C15SEVs and recombinant Galectin-9 on peripheral blood mononuclear cells (Lefebvre et al., 2023; PMID: 38117000). |
Expiration Date | 12 months from date of receipt. |
IF, IHC-Fr, IHC-P | |
Human, Rat | |
Human, Mouse, Rat | |
Rabbit | |
Polyclonal | |
Unconjugated |